N. Anthony Coles
N. Anthony Coles | |
|---|---|
| Born | Neavelle Anthony Coles May 17, 1960 Roanoke, Virginia, U.S. |
| Education | Johns Hopkins University (BA) Harvard University (MPH) Duke University (MD) |
| Occupation(s) | Physician, biotechnology executive |
| Spouse | Robyn Coles |
| Children | 3 |
Neavelle Anthony Coles (born May 17, 1960) is an American physician and biotechnology executive. He has served as chairman of the board of directors of Cerevel Therapeutics, a company focused on neurological disease treatments, since 2018, and was its chief executive officer from 2019 to 2023.[1][2]
Early life and education
[edit]Coles was born in Roanoke, Virginia, to Neavelle Anthony Coles, an accountant and minister, and Leona Rogers Coles, an office manager.[3] He graduated from DuVal High School in Lanham, Maryland.[4]
Coles earned a Bachelor of Arts from Johns Hopkins University, a Master of Public Health from Harvard University, and a Doctor of Medicine from Duke University.[1] He completed cardiology and internal medicine training at Massachusetts General Hospital and a research fellowship at Harvard Medical School.[5] In 2024, Duke University School of Medicine honored him with its Transformational Leadership Award.[6]
Career
[edit]Coles began his career in pharmaceuticals, holding executive roles at Merck & Co. (marketing ACE inhibitors), Bristol-Myers Squibb (senior vice president of strategy and policy, and marketing for neuroscience and infectious diseases), and Vertex Pharmaceuticals (senior vice president of commercial operations).[4][1]
From 2005 to 2008, Coles served as chief operating officer and president of NPS Pharmaceuticals, becoming chief executive officer in 2006.[7] He was president and CEO of Onyx Pharmaceuticals from 2008 to 2013, and chairman from 2012 to 2013, overseeing its $10.4 billion sale to Amgen in 2013.[1][8]
In 2014, Coles co-founded Yumanity Therapeutics with Susan Lindquist, serving as chairman and CEO until 2018, focusing on treatments for Alzheimer’s and Parkinson’s diseases.[8][3] Since 2013, he has been chairman and CEO of TRATE Enterprises, a private real estate and ventures company.[9]
At Cerevel Therapeutics, Coles served as CEO from 2019 to 2023, leading a $445 million public listing in 2020, and has been chairman since 2018.[2][1] He also serves on the board of directors of Regeneron Pharmaceuticals.[9] In 2021, he was elected to the American Academy of Arts and Sciences.[10]
Civic and professional affiliations
[edit]Coles is co-founder and co-chair of the Black Economic Alliance, a nonprofit focused on economic equity.[11] He serves on the boards of the Metropolitan Museum of Art, the Council on Foreign Relations, and the U.S. Olympic and Paralympic Foundation, and is a former trustee of Johns Hopkins University.[12][5][13]
Personal life
[edit]Coles is married to Robyn Coles, and they have three sons. Their eldest son was diagnosed with non-Hodgkin’s lymphoma at age 12 and underwent treatment at Memorial Sloan Kettering Cancer Center.[14]
References
[edit]- ^ a b c d e Langreth, Robert (May 3, 2023). "Cerevel CEO Tony Coles Steps Down From Neuroscience Biotech". Bloomberg News. Retrieved May 1, 2025.
- ^ a b Herper, Matthew (July 30, 2020). "Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects". STAT. Retrieved May 1, 2025.
- ^ a b "Driven To Serve As Many Lives As Possible". Korn Ferry. Retrieved May 1, 2025.
- ^ a b "Dr. Tony Coles". The HistoryMakers. Retrieved May 1, 2025.
- ^ a b "Tony Coles, M.D., M.P.H." All of Us Research Program, National Institutes of Health. Archived from the original on January 22, 2019. Retrieved May 1, 2025.
- ^ "2024 Transformational Leadership Award: N. Anthony Coles, MD'86, MPH". Duke University School of Medicine. June 26, 2024. Retrieved May 1, 2025.
- ^ "NPS Pharmaceuticals, Inc. Elects N. Anthony Coles, M.D. Chief Executive Officer". BioSpace. May 12, 2006. Retrieved May 1, 2025.
- ^ a b Carroll, John (December 15, 2014). "UPDATED: Onyx vet Tony Coles embarks on a new biotech adventure". Fierce Biotech. Retrieved May 1, 2025.
- ^ a b "Tony Coles, M.D." Regeneron Pharmaceuticals. Retrieved May 1, 2025.
- ^ "Tony Coles". American Academy of Arts and Sciences. April 22, 2021. Retrieved May 1, 2025.
- ^ "Tony Coles, MD". Black Economic Alliance PAC. May 28, 2018. Retrieved May 1, 2025.
- ^ "Metropolitan Museum Elects New Trustees". Metropolitan Museum of Art. May 12, 2015. Retrieved May 1, 2025.
- ^ "Trustees". Johns Hopkins University Board of Trustees. Retrieved May 1, 2025.
- ^ "Biopharma CEO: You Really Get It When You're Treating Your Own Son". CNBC. March 20, 2013. Retrieved May 1, 2025.